GCP
SLS icon

GSA Capital Partners’s SELLAS Life Sciences SLS Stock Holding History

GSA Capital Partners’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$691K Sell
163,290
-181,762
-53% -$813K 0.04% 719
2025
Q4 		$1.3M Sell
345,052
-173,943
-34% -$338K 0.11% 233
2025
Q3 		$836K Buy
518,995
+92,411
+22% +$165K 0.07% 519
2025
Q2 		$934K Buy
426,584
+403,857
+1,777% +$620K 0.07% 507
2025
Q1 		$25K Buy
+22,727
New +$27K ﹤0.01% 1577
2022
Q1 		– Sell
-10,447
Closed -$58K – 1799
2021
Q4 		$58K Buy
+10,447
New +$79K 0.01% 1344

Other funds holding SLS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM